EGFR NP_005219.2:p.T790M

Preferred Label : EGFR NP_005219.2:p.T790M;

NCIt synonyms : NP_005219.2:p.Thr790Met; Receptor Tyrosine-Protein Kinase erbB-1 T790M; Epidermal Growth Factor Receptor T790M; EGFR p.Thr790Met; EGFR Thr790Met; EGFR NP_005219.2:p.Thr790Met; EGFR p.T790M; Proto-Oncogene c-ErbB-1 T790M; EGFR T790M; T790M; EGFR T790M TKI Resistant Mutation; EGFR T790M Resistant Mutation; EGFR T790 Resistant Mutation;

NCIt related terms : Exon 20 Thr790Met;

NCIt definition : A change in the amino acid residue at position 790 in the epidermal growth factor receptor protein where threonine has been replaced by methionine.;

Details

Origin ID

C98503;

UMLS CUI

C3274192;

Semantic type(s)
- Cell or Molecular Dysfunction [UMLS semantic type]
concept_is_in_subset
- CPTAC Baseline Medical Forms Terminology [NCIt concept]
- CPTAC Lung Squamous Cell Carcinoma and Lung Adenocarcinoma Baseline Form [NCIt concept]
- CPTAC Terminology [NCIt concept]
- CTRP Biomarker Terminology [NCIt concept]
- CTRP Disease Terminology [NCIt concept]
- CTRP Molecular Genetic Biomarker Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
gene_product_sequence_variation_encoded_by_gene_mutant
- Activating EGFR Gene Mutation [NCIt concept]
- EGFR Gene Mutation [NCIt concept]
- EGFR NM_005228.3:c.2369C>T [NCIt concept]
- EGFR-TKI Resistant Mutation [NCIt concept]
gene_product_variant_of_gene_product
- Epidermal Growth Factor Receptor [NCIt concept]
is_target
- Abivertinib [NCIt concept]
- Abivertinib Maleate [NCIt concept]
- Abivertinib Maleate Anhydrous [NCIt concept]
- Alflutinib Mesylate [NCIt concept]
- Aumolertinib [NCIt concept]
- Befotertinib [NCIt concept]
- Carbon C14 EGFR Inhibitor ASP8273 [NCIt concept]
- EGFR Inhibitor WJ13404 [NCIt concept]
- EGFR Inhibitor XZP-5809 [NCIt concept]
- EGFR Inhibitor XZP-5809 Tartrate [NCIt concept]
- EGFR Mutant-selective Inhibitor FWD1509 MsOH [NCIt concept]
- EGFR Mutant-selective Inhibitor PLB1004 [NCIt concept]
- EGFR Mutant-selective Inhibitor QLH11811 [NCIt concept]
- EGFR Mutant-selective Inhibitor TRX-221 [NCIt concept]
- EGFR Mutant-selective Inhibitor WZ4002 [NCIt concept]
- EGFR Mutant-selective Inhibitor YK-029A [NCIt concept]
- EGFR Mutant-specific Inhibitor CK-101 [NCIt concept]
- EGFR Mutant-specific Inhibitor ZN-e4 [NCIt concept]
- EGFR T790M Antagonist BPI-15086 [NCIt concept]
- Firmonertinib [NCIt concept]
- Keynatinib [NCIt concept]
- Lazertinib [NCIt concept]
- Lazertinib Mesylate Monohydrate [NCIt concept]
- Mavelertinib [NCIt concept]
- Olmutinib [NCIt concept]
- Osimertinib [NCIt concept]
- Osimertinib Mesylate [NCIt concept]
- Tigozertinib [NCIt concept]
molecular_abnormality_involves_gene
- EGFR Gene [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients